GLPwatch
Bydureon vs Byetta
Drug comparison
Last updated 2026-05-28 15:46 UTCBydureon and Byetta are both injectable medications for type 2 diabetes, made by AstraZeneca and containing the same active ingredient, exenatide. The main difference is that Bydureon is taken once a week, while Byetta is taken twice a day.
AI summary of the sources below.
| Bydureon | Byetta | |
|---|---|---|
| Active ingredient | exenatide | exenatide |
| Manufacturer | astrazeneca | astrazeneca |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | — | 2025-09-02 |